Welcome to our dedicated page for Lifemd SEC filings (Ticker: LFMDP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for LifeMD, Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) provides access to regulatory documents filed by LifeMD, Inc., the issuer of this preferred security. These filings, drawn from the SEC’s EDGAR system, include current reports on Form 8‑K and other disclosures that reference both the company’s common stock and its 8.875% Series A Cumulative Perpetual Preferred Stock.
LifeMD’s Form 8‑K filings illustrate how SEC reports can inform investors in LFMDP. For example, the company has filed 8‑Ks describing changes in its independent registered public accounting firms, including the dismissal of prior auditors, the identification of material weaknesses in internal control over financial reporting, and the appointment of PricewaterhouseCoopers LLP. Other 8‑Ks discuss the release of financial results for specific periods and the furnishing of related press releases as exhibits.
These filings also show how LifeMD reports broader corporate events that may be relevant to preferred stockholders. The company has disclosed the divestiture of its majority interest in WorkSimpli Software LLC, positioning LifeMD as a pure‑play virtual care and pharmacy platform, and has described its focus on expanding virtual care and pharmacy offerings. In addition, press releases incorporated into filings and separate company announcements detail quarterly cash dividends authorized on the 8.875% Series A Cumulative Perpetual Preferred Stock, directly affecting LFMDP holders.
Through this page, users can review LifeMD’s filed balance sheets, statements of operations, and related notes where the Series A Preferred Stock is presented within the capital structure, including information about authorized and outstanding shares. Current reports also reference the preferred stock explicitly in the context of material events and exhibit listings.
Stock Titan enhances this raw filing data with AI‑powered summaries that explain the key points of complex documents in plain language. As new LifeMD filings are posted to EDGAR, they are updated on this page, allowing investors to quickly see how changes in auditors, internal controls, financial reporting, corporate transactions, or dividend decisions might relate to LFMDP. Users can also review filings that touch on executive appointments, compensation arrangements, and other governance topics that shape the environment in which the preferred stock exists.